Investigation of Kidney Morphology and Somatotype Components in Early-Stage Kidney Patients

Overview

Journal Sisli Etfal Hastan Tıp Bul

Specialty General Medicine

Date 2023 Oct 30

PMID 37900334

Authors

Hilal Er Ulubaba

Fahri Safa Cinarli

Rukiye Ciftci

Ozkan Ulutas

Affiliations

Soon will be listed here.

Abstract

Objectives: The aim of this study is to examine the kidney morphology and somatotype components of adult patients with early-stage chronic kidney disease (CKD).

Methods: The sample consisted of 46 individuals with early-stage CKD (26 men and 20 women, mean age=45.92±16.53 years). The pathological subjects were compared with a control group consisting of 46 healthy subjects (28 men and 18 women, mean age=41.96±11.48 years). The Heath-Carter method was used to determine somatotype components. Abdominal computed tomography (CT) of patients with Stage 2 CKD and healthy volunteers taken within the past 3 months was scanned to determine kidney morphology. Kidney measurements were performed on CTs (length, width, depth, and volume of kidney).

Results: Kidney patients (mean somatotype: 6.33-5.37-0.6) were less ectomorphic and more endomorphic than the controls (mean somatotype: 4.35-4.40-3.02). Moderate effect size (ES) was found in endomorphy (ES=0.87; p=0.035) and ectomorphy (ES=1.08; p=0.012) between groups. No significant difference was observed in the kidney morphology (ES=0.04-0.19; p>0.05).

Conclusion: In the early-stage CKD, kidney morphology may not be the distinguishing factor. On the other hand, patients differed significantly in terms of endomorph components. Being overweight can also be one of the negative findings for kidney disease. Somatotype classification could be a suitable tool for monitoring kidney disease.

References

Okur A, Serin H, Zengin K, Erkoc M, Tanik S, Yildirim U . Relationship between kidney volume and body indexes in the Turkish population determined using ultrasonography. Int Braz J Urol. 2015; 40(6):816-22. DOI: 10.1590/S1677-5538.IBJU.2014.06.13. View

Sharma K, Caroli A, Quach L, Petzold K, Bozzetto M, Serra A . Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease. PLoS One. 2017; 12(5):e0178488. PMC: 5448775. DOI: 10.1371/journal.pone.0178488. View

Johnson N, George J . Fitness versus fatness: moving beyond weight loss in nonalcoholic fatty liver disease. Hepatology. 2010; 52(1):370-81. DOI: 10.1002/hep.23711. View

Levey A, Eckardt K, Tsukamoto Y, Levin A, Coresh J, Rossert J . Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005; 67(6):2089-100. DOI: 10.1111/j.1523-1755.2005.00365.x. View

Altun B, Suleymanlar G, Utas C, Arinsoy T, Ates K, Ecder T . Prevalence, awareness, treatment and control of hypertension in adults with chronic kidney disease in Turkey: results from the CREDIT study. Kidney Blood Press Res. 2012; 36(1):36-46. DOI: 10.1159/000339025. View

El-Reshaid W, Abdul-Fattah H . Sonographic assessment of renal size in healthy adults. Med Princ Pract. 2014; 23(5):432-6. PMC: 5586921. DOI: 10.1159/000364876. View

Wykretowicz M, Katulska K, Milewska A, Krauze T . Left ventricular mass: correlation with fatness, hemodynamics and renal morphology. Pol J Radiol. 2014; 79:426-30. PMC: 4245148. DOI: 10.12659/PJR.891166. View

Koleva M, Nacheva A, Boev M . Somatotype and disease prevalence in adults. Rev Environ Health. 2002; 17(1):65-84. DOI: 10.1515/reveh.2002.17.1.65. View

Buffa R, Lodde M, Floris G, Zaru C, Putzu P, Marini E . Somatotype in Alzheimer's disease. Gerontology. 2007; 53(4):200-4. DOI: 10.1159/000100486. View

10.

Katzmarzyk P, Malina R, Song T, Bouchard C . Physique, subcutaneous fat, adipose tissue distribution, and risk factors in the Québec Family Study. Int J Obes Relat Metab Disord. 1999; 23(5):476-84. DOI: 10.1038/sj.ijo.0800844. View

11.

Luyckx V, Brenner B . The clinical importance of nephron mass. J Am Soc Nephrol. 2010; 21(6):898-910. DOI: 10.1681/ASN.2009121248. View

12.

Byers T, Sedjo R . Body fatness as a cause of cancer: epidemiologic clues to biologic mechanisms. Endocr Relat Cancer. 2015; 22(3):R125-34. DOI: 10.1530/ERC-14-0580. View

13.

Williams S, Goodfellow J, Davies B, Bell W, McDowell I, Jones E . Somatotype and angiographically determined atherosclerotic coronary artery disease in men. Am J Hum Biol. 2001; 12(1):128-138. DOI: 10.1002/(SICI)1520-6300(200001/02)12:1<128::AID-AJHB14>3.0.CO;2-X. View

14.

Talhar S, Waghmare J, Paul L, Kale S, Shende M . Computed Tomographic Estimation of Relationship between Renal Volume and Body Weight of an Individual. J Clin Diagn Res. 2017; 11(6):AC04-AC08. PMC: 5535333. DOI: 10.7860/JCDR/2017/25275.10010. View

15.

Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2095-128. PMC: 10790329. DOI: 10.1016/S0140-6736(12)61728-0. View

16.

Hanamura K, Tojo A, Kinugasa S, Asaba K, Fujita T . The resistive index is a marker of renal function, pathology, prognosis, and responsiveness to steroid therapy in chronic kidney disease patients. Int J Nephrol. 2013; 2012:139565. PMC: 3533455. DOI: 10.1155/2012/139565. View

17.

Genc D, Akinci N, Yildirmak Z, Vural S . Renal Ultrasonographic Abnormalities at Initial Presentation of Children Diagnosed with Acute Lymphoblastic Leukemia and Long-Term Renal Functions and Prognosis in Survivors. Sisli Etfal Hastan Tıp Bul. 2022; 56(3):421-426. PMC: 9580970. DOI: 10.14744/SEMB.2022.89646. View

18.

Renehan A, Tyson M, Egger M, Heller R, Zwahlen M . Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008; 371(9612):569-78. DOI: 10.1016/S0140-6736(08)60269-X. View

19.

Jiang Z, Qin J, Liang K, Zhao R, Yan F, Hou X . Self-reported snoring is associated with chronic kidney disease in obese but not in normal-weight Chinese adults. Ren Fail. 2021; 43(1):709-717. PMC: 8079005. DOI: 10.1080/0886022X.2021.1915332. View

20.

Cuppari L . Diagnosis of obesity in chronic kidney disease: BMI or body fat?. Nephrol Dial Transplant. 2013; 28 Suppl 4:iv119-21. DOI: 10.1093/ndt/gft266. View